OneAI™ provides repeatable, multidimensional biospectral characterization designed to support comparison between biosimilar and reference biologic products.
Biosimilar development depends on demonstrating that a proposed product is highly similar to its reference product.
OneAI™ can compare biospectral signatures across products, samples and lots—providing objective measurements of similarity, consistency and change.
It is designed to complement established analytical methods, not replace them, by adding a repeatable characterization layer to the analytical comparability framework.
Purity Biologics is working with experienced biosimilar development and regulatory experts to evaluate how OneAI™-generated data can be incorporated into structured comparability and regulatory-development frameworks.
Current work is focused on applying the technology to real biosimilar analytical data and defining where OneAI can provide additional evidentiary value.
Copyright © 2026 Purity Biologics Inc - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.